Home › Left Ventricular Dysfunction › Ohio › Cleveland
Left Ventricular Dysfunction clinical trials in Cleveland, OH
4 studies for Left Ventricular Dysfunction are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Cleveland Clinic Children's, Cleveland
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Cleveland Clinic Children's, Cleveland
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Recruiting
- University Hospitals Cleveland Medical Center, Cleveland
Left Ventricular Dysfunction trials in other cities
- New York City, NY4 studies
- Boston, MA3 studies
- Aurora, CO3 studies
- Pittsburgh, PA3 studies
- Cincinnati, OH3 studies
- The Bronx, NY3 studies
- Houston, TX3 studies
- Philadelphia, PA3 studies
- Atlanta, GA3 studies
- Ann Arbor, MI3 studies
- Dallas, TX3 studies
- St. Louis, MO3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer44 studies
- Cancer (all types)37 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer28 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer21 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.